Widespread Off-Label Use Could Ensure Injectable Bacitracin's Future

Medication drug needle syringe
The US FDA is asking its external experts whether bacitracin injection should remain on the market. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers